VSIR and cancer: Specifically, methionine facilitates m6A RNA modification and the translation of PD-L1 and V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA) in cancer cells, thereby suppressing anti-cancer immunity [69].